Woodmont Investment Counsel’s Ligand Pharmaceuticals LGND Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-29	Closed	-$2K	–	432
2016 Q3	$2K	Buy	+29	New	+$2K	﹤0.01%	650